| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:46 | MAYNE PHARMA GROUP LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 06:17 | HSI Adds 135 Pts at Midday as BYD COMPANY Leaps 4%+; CSPC PHARMA Surges 10% | 29 | AASTOCKS | ||
| 05:17 | HSI Closes Midday at 24,992, Up 135 pts; HSTI Closes Midday at 4,811, Up 50 pts; CSPC PHARMA Up over 9%; XUNCE, WASION HOLDINGS, GANFENGLITHIUM, QINGSONG HEALTH, HUISHANG BANK Hit New Highs | 4 | AASTOCKS | ||
| 05:17 | SSY Group Full-Year Net Profit HKD471 Million Down 55.6%, Final Dividend Reduced to HKD0.03 | 1 | AASTOCKS | ||
| 05:15 | SHINEWAY PHARM (02877): FIRST INTERIM DIVIDEND IN RESPECT OF THE FISCAL YEAR 2026 | 1 | HKEx | ||
| 05:03 | SSY GROUP (02005): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| 05:01 | SHINEWAY PHARM (02877): 2025 ANNUAL RESULTS ANNOUNCEMENT AND DECLARATION OF 2026 FIRST INTERIM DIVIDEND | 1 | HKEx | ||
| 05:00 | SSY GROUP (02005): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | 2 | HKEx | ||
| 04:17 | Citi Notes CSPC Pharmaceutical Last Year's Profit Missed Expectations, TP Lowered to HKD10, Reiterates 'Buy' | 2 | AASTOCKS | ||
| 03:47 | BofAS Cuts TP for CSPC PHARMA to HKD8, Rating Underperform | 2 | AASTOCKS | ||
| 03:47 | Nomura: CSPC Pharmaceutical Last Year's Net Profit Far Below Expectations Due to One-off Factors | 2 | AASTOCKS | ||
| 03:47 | CMBI Raises TP of WUXI BIO to HKD39, Maintains 'Buy' Rating | 3 | AASTOCKS | ||
| 03:26 | RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over "Modest Premium" | 6 | Insider Monkey | ||
| 03:26 | Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data | 6 | Insider Monkey | ||
| 03:10 | HotList stocks: Amplia, Turnstone, Xenitra, and other trending companies in Week 13 | 1 | The Market Herald Australia | ||
| 02:59 | Hims & Hers Expands Access To Novo Nordisk's FDA-Approved GLP-1 Medications, Including Wegovy Pill | 17 | RTTNews | ||
| 02:42 | XORTX Therapeutics Inc (3): XORTX Therapeutics rollback effective date | 1 | Stockwatch | ||
| 02:17 | LEE'S PHARM Last Year's Loss Expanded to USD4.71 Million | 1 | AASTOCKS | ||
| 01:18 | XORTX Therapeutics Inc (3): XORTX Therapeutics shareholders approve AGM resolutions | 5 | Stockwatch | ||
| 00:54 | BC Securities Commission: BCSC halts Noveris Health after incorrect FDA claim | 1 | Stockwatch |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES | 24 | 2 | +1,87 % | Wave Life Sciences Ltd.: Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following ... | At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p WVE-007 led to greater improvement in... ► Artikel lesen | ||
| NOVO NORDISK | 22 | 40 | +0,27 % | HV-Termine: Hauptversammlungen bei Andritz, Carl Zeiss Meditec, Hoenle, Nordea, Novo Nordisk, Sartorius | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | ||
| MERCK & CO | 8 | 43 | +0,19 % | Opening Bell: Öl, Chevron, TotalEnergies, Gold, Newmont, Arm Holdings, Merck & Co., General Motors | Die US-Börsen haben am Dienstag nachgegeben. Der Dow Jones verlor 0,18 Prozent, der Nasdaq Composite fiel 0,84 Prozent. Die Anleger agieren angesichts der unklaren Lage im Iran-Krieg weiterhin vorsichtig.... ► Artikel lesen | ||
| CSPC PHARMA | 6 | 3 | -5,28 % | Jefferies Raises TP for CSPC Pharmaceutical Group to HKD7.2, Maintains 'Underperform' Rating | |||
| OXFORD BIOMEDICA | 6 | - | -5,80 % | Oxford Biomedica FY 2025 slides: CDMO turns profitable on 33% revenue surge | |||
| DARE BIOSCIENCE | 6 | - | +8,21 % | Daré outlines 2026 revenue launch and multiplatform strategy as DARE to PLAY expands nationwide | |||
| XORTX THERAPEUTICS | 6 | - | -2,61 % | XORTX Therapeutics Inc.: XORTX Announces Share Consolidation | CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | ||
| BAYER | 5 | 36 | +0,38 % | DAX-Check LIVE: Aroundtown, Bayer, Beiersdorf, Elmos, Fuchs, Infineon, Lanxess im Fokus | Die Eskalation im Nahost-Krieg hat die Märkte erneut stark belastet. Steigende Energiepreise und wachsende Konjunktursorgen sorgten für eine deutliche Flucht aus Aktien. Der DAX sackte im Tagesverlauf... ► Artikel lesen | ||
| TILRAY BRANDS | 5 | 7 | -0,35 % | Panik vor Kursbeben: Das Zittern beginnt: Reißen die Tilray-Zahlen Canopy, Aurora & Co in die Tiefe? | © Foto: adobe.stock.comIn Kürze ist es soweit - Tilray wird frische Quartalszahlen vorlegen. Den Tilray-Zahlen kann man dabei durchaus richtungsweisenden Charakter zubilligen. Entsprechend dürften sie... ► Artikel lesen | ||
| LIGAND PHARMACEUTICALS | 5 | 2 | +0,56 % | Ligand Pharmaceuticals: Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team | JUPITER, Fla., March 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed two leading healthcare investors, Peter Renehan, MD, and Lee Brown... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| DOCMORRIS AG | 4,600 | 7,37 | +60 % | 6 | 9 | 4 | |||
| SCHOTT PHARMA AG & CO KGAA | 13,500 | 18,70 | +39 % | 3 | 10 | - | |||
| MERCK KGAA | 106,90 | 141,60 | +32 % | 12 | 8 | - | |||
| ELI LILLY AND COMPANY | 780,40 | 968,78 | +24 % | 1 | - | - | |||
| ASTRAZENECA PLC | 159,00 | 190,61 | +20 % | 20 | 1 | 6 | |||
| NOVO NORDISK A/S | 31,920 | 37,42 | +17 % | 17 | 26 | 3 | |||
| SANOFI SA | 81,21 | 94,57 | +16 % | 12 | 16 | - | |||
| BAYER AG | 38,275 | 41,71 | +9 % | 26 | 11 | 1 | |||
| NOVARTIS AG | 129,10 | 129,55 | +0 % | 6 | 13 | 3 | |||
| PFIZER INC | 23,960 | 23,93 | 0 % | 1 | 5 | - | |||
| GSK PLC | 23,660 | 23,51 | -1 % | 4 | 11 | 14 | |||
| DERMAPHARM HOLDING SE | 44,500 | 34 | -24 % | - | 1 | - |